Cargando…

Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.

Loss of heterozygosity (LOH) on chromosome arm 16q occurs in 48-65% of breast tumours. One small region of overlap is located at 16q24.3. Two genes located in this region, the cellular adhesion regulatory molecule (CMAR) and the breast basic conserved gene (BBC1), are plausible candidate tumour-supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Moerland, E., Breuning, M. H., Cornelisse, C. J., Cleton-Jansen, A. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228200/
https://www.ncbi.nlm.nih.gov/pubmed/9413939
_version_ 1782149855716573184
author Moerland, E.
Breuning, M. H.
Cornelisse, C. J.
Cleton-Jansen, A. M.
author_facet Moerland, E.
Breuning, M. H.
Cornelisse, C. J.
Cleton-Jansen, A. M.
author_sort Moerland, E.
collection PubMed
description Loss of heterozygosity (LOH) on chromosome arm 16q occurs in 48-65% of breast tumours. One small region of overlap is located at 16q24.3. Two genes located in this region, the cellular adhesion regulatory molecule (CMAR) and the breast basic conserved gene (BBC1), are plausible candidate tumour-suppressor genes. Mutational analysis of the retained copy of these genes has been performed by direct sequencing in a selected set of breast tumours that show LOH at 16q24.3 but not at other regions on chromosome arm 16q. In CMAR no other alterations than the previously described 4-bp insertion of CACA at nucleotide 241 could be detected, which was also present in constitutional DNA of the same patients. This polymorphism occurs homozygously in germline DNA of normal individuals and breast cancer patients. LOH analysis at this locus shows no preferential loss of a particular variant of the 241 polymorphism. In the BBC1 gene, three different alterations were found, but only one resulted in an amino acid substitution. This is a known polymorphism, however, also appearing in germline DNA. The absence of tumour-specific mutations in CMAR and BBC1 in this selected series of breast tumours implies that another gene at 16q24.3 must be the tumour-suppressor gene that is the target for LOH in breast cancer. IMAGES:
format Text
id pubmed-2228200
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22282002009-09-10 Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes. Moerland, E. Breuning, M. H. Cornelisse, C. J. Cleton-Jansen, A. M. Br J Cancer Research Article Loss of heterozygosity (LOH) on chromosome arm 16q occurs in 48-65% of breast tumours. One small region of overlap is located at 16q24.3. Two genes located in this region, the cellular adhesion regulatory molecule (CMAR) and the breast basic conserved gene (BBC1), are plausible candidate tumour-suppressor genes. Mutational analysis of the retained copy of these genes has been performed by direct sequencing in a selected set of breast tumours that show LOH at 16q24.3 but not at other regions on chromosome arm 16q. In CMAR no other alterations than the previously described 4-bp insertion of CACA at nucleotide 241 could be detected, which was also present in constitutional DNA of the same patients. This polymorphism occurs homozygously in germline DNA of normal individuals and breast cancer patients. LOH analysis at this locus shows no preferential loss of a particular variant of the 241 polymorphism. In the BBC1 gene, three different alterations were found, but only one resulted in an amino acid substitution. This is a known polymorphism, however, also appearing in germline DNA. The absence of tumour-specific mutations in CMAR and BBC1 in this selected series of breast tumours implies that another gene at 16q24.3 must be the tumour-suppressor gene that is the target for LOH in breast cancer. IMAGES: Nature Publishing Group 1997 /pmc/articles/PMC2228200/ /pubmed/9413939 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Moerland, E.
Breuning, M. H.
Cornelisse, C. J.
Cleton-Jansen, A. M.
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title_full Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title_fullStr Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title_full_unstemmed Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title_short Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
title_sort exclusion of bbc1 and cmar as candidate breast tumour-suppressor genes.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228200/
https://www.ncbi.nlm.nih.gov/pubmed/9413939
work_keys_str_mv AT moerlande exclusionofbbc1andcmarascandidatebreasttumoursuppressorgenes
AT breuningmh exclusionofbbc1andcmarascandidatebreasttumoursuppressorgenes
AT cornelissecj exclusionofbbc1andcmarascandidatebreasttumoursuppressorgenes
AT cletonjansenam exclusionofbbc1andcmarascandidatebreasttumoursuppressorgenes